Edward Doerffler

2.8k total citations
10 papers, 179 citations indexed

About

Edward Doerffler is a scholar working on Infectious Diseases, Hepatology and Organic Chemistry. According to data from OpenAlex, Edward Doerffler has authored 10 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Hepatology and 4 papers in Organic Chemistry. Recurrent topics in Edward Doerffler's work include Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Edward Doerffler is often cited by papers focused on Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (4 papers) and Hepatitis B Virus Studies (3 papers). Edward Doerffler collaborates with scholars based in United States and United Kingdom. Edward Doerffler's co-authors include Xiaowu Chen, Choung U. Kim, William E. Delaney, Michael O. Clarke, Hyung‐Jung Pyun, Timothy E. Patten, Rowchanak Pakdaman, Aesop Cho, Georgina To’a Salazar and Aaron Chen and has published in prestigious journals such as Macromolecules, Langmuir and Tetrahedron Letters.

In The Last Decade

Edward Doerffler

9 papers receiving 174 citations

Peers

Countries citing papers authored by Edward Doerffler

Since Specialization

Citations

This map shows the geographic impact of Edward Doerffler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Doerffler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Doerffler more than expected).

Fields of papers citing papers by Edward Doerffler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Doerffler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Doerffler. The network helps show where Edward Doerffler may publish in the future.

Co-authorship network of co-authors of Edward Doerffler

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Doerffler. A scholar is included among the top collaborators of Edward Doerffler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Doerffler. Edward Doerffler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Early Development and Kilogram Scale-Up of a Non-steroidal FXR Agonist for the Treatment of Non-alcoholic Steatohepatitis (NASH) 2021 ·Organic Process Research & Development ·(unknown), (unknown), Edward Doerffler, (unknown), (unknown), (unknown), (unknown), (unknown), Adam B. Weinstein, (unknown)	0
2	Discovery of β-d-2′-deoxy-2′-α-fluoro-4′-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases 2015 ·Bioorganic & Medicinal Chemistry Letters ·Michael O. Clarke, Richard L. Mackman, Daniel Byun, Hon C. Hui, Ona Barauskas, Gabriel Birkuš, (unknown), Edward Doerffler, Joy Y. Feng, Kapil Karki, Gary Lee, Michel Perron, Dustin S. Siegel, S. Swaminathan, William Lee	20
3	Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), T.C. Appleby, Thomas Butler, Ruby Cai, Xiaowu Chen, Aesop Cho, Michael O. Clarke, (unknown), William E. Delaney, Edward Doerffler, John O. Link, (unknown), Rowchanak Pakdaman, Hyung‐Jung Pyun, Qiaoyin Wu, Jie Xu, Choung U. Kim	26
4	Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Anthony Casarez, Ruby Cai, Michael O. Clarke, Xiaowu Chen, Aesop Cho, William E. Delaney, Edward Doerffler, (unknown), Michael Mertzman, Rowchanak Pakdaman, Hyung‐Jung Pyun, (unknown), Qiaoyin Wu, Jie Xu, Choung U. Kim	28
5	Novel, potent and orally bioavailable indolizidinone-derived inhibitors of the hepatitis C virus NS3 protease 2011 ·Bioorganic & Medicinal Chemistry Letters ·Michael O. Clarke, Daniel Byun, Xiaowu Chen, Edward Doerffler, Stephanie A. Leavitt, (unknown), Cheng Yong Yang, Choung U. Kim	9
6	Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease 2011 ·Bioorganic & Medicinal Chemistry Letters ·Michael O. Clarke, Xiaowu Chen, Aesop Cho, William E. Delaney, Edward Doerffler, Maria Fardis, (unknown), Michael Mertzman, Rowchanak Pakdaman, (unknown), (unknown), Cheng Yong Yang, (unknown), Choung U. Kim	18
7	Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hyung‐Jung Pyun, Kleem Chaudhary, Jian‐Ying Wang, Edward Doerffler, (unknown), (unknown), Xiaowu Chen, William E. Delaney, Choung U. Kim	34
8	The synthesis of 2-ketopiperazine acetic acid esters and amides from ethylenediamines with maleates and maleimides 2003 ·Tetrahedron Letters ·Matthew M. Abelman, (unknown), Edward Doerffler, Paul Edwards	10
9	Poly(4-(aminomethyl)styrene)-b-polystyrene: Synthesis and Unilamellar Vesicle Formation 2002 ·Langmuir ·(unknown), Mark A. Borden, (unknown), Edward Doerffler, Georgina To’a Salazar, Aaron Chen, (unknown), Joseph A. Zasadzinski, Timothy E. Patten, Marjorie L. Longo	28
10	Benzyl Acetate and Benzyl Ether Groups as Latent Initiator Sites for Atom Transfer Radical Polymerization 2000 ·Macromolecules ·Edward Doerffler, Timothy E. Patten	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact